Home » Topics » BioWorld Science

BioWorld Science
RSS

Promising phase II results for TOP-1630 in dry eye syndrome

May 9, 2018

Celgene presents highlights of first quarter 2018

May 9, 2018

Biohaven establishes expanded access program for sublingual BHV-0223 for ALS

May 9, 2018

Atara Biotherapeutics expands collaboration with Memorial Sloan Kettering

May 9, 2018

Researchers present INT-1B3 as a promising antitumoral compound

May 9, 2018

Phase III TAGS trial of Lonsurf in metastatic gastric cancer meets primary endpoint

May 9, 2018

Alternative targeting of IDO pathway: New developments from the AAI annual meeting

May 9, 2018

Novo Nordisk reviews pipeline highlights of first quarter 2018

May 9, 2018

Janssen Pharma launches Sirturo Tablets in Japan

May 9, 2018

MG7-CART therapy evaluated for the first time in a patient with metastatic colorectal cancer

May 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...